The really exciting thing is that we are just getting started.”ġ0x Genomics, Inc. “We have been fortunate to achieve leadership positions across multiple scientific fields in a short amount of time. “We are thrilled to partner with Meritech, Wells Fargo, and our other investors to drive the next phase of our growth,” said Serge Saxonov, CEO and Co-founder of 10x Genomics. The funding will also help 10x to continue to expand its global commercial organization, including new offices in Leiden, The Netherlands and Shanghai, PRC, as well as to expand its internal manufacturing capabilities.
The proceeds from these financings will fuel the Company’s innovation engine and will allow investment in new strategic opportunities. It is rare to see a company with this much existing success as well as massive potential to impact the world in a positive way,“ said Craig Sherman, managing director of Meritech Capital. 10x has had a remarkable record of brilliant execution in the service of an ambitious vision. “We invest exclusively in late stage companies with big potential.
#10x chromium boston install
All of these new products are designed for the Company’s Chromium instrument whose global install base now stands at over 600. In its first thirty months of sales, the Company has had twenty-five product launches spanning instruments, reagents and software.įor 2018 the Company has shared plans for multiple new products including fundamental new capabilities such as single cell DNA sequencing for oncology, single cell multi-omic measurements of proteins and gene expression, and single cell epigenomic analysis. The Company complemented this financing with a new $75 million debt facility with Silicon Valley Bank.Įarlier this year, at the JPMorgan Healthcare conference, 10x announced that it had achieved over $100 million in revenue since first product introduction in mid-2015, and that its revenues had increased over 150% year over year.
It was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity and the SoftBank Group.
#10x chromium boston series
The funding included a $50 million Series D financing. Pleasanton, CA.ġ0x Genomics–SEVERAL: investment, 201804 financing round Series D $50m led by Meritech Capital Partnersġ0x Genomics–SVB: credit, 201804– debt facility $75m with Silicon Valley Bankġ0x Genomics, a company focused on accelerating genomic discovery, today announced that it had raised $125 million in funding. "Press Release: 10x Genomics Completes $50 Million Series D Financing and $75M Debt Facility".
0 kommentar(er)
